epirubicin has been researched along with Lymphoma, B-Cell in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 15 (68.18) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Chen, H; He, B; Kang, Y; Shen, L; Shen, X; Wang, W; Xiao, F; Zhao, H | 1 |
| Alexander, C; Connors, JM; Gascoyne, RD; Hamilton, SN; Tan, K; Wai, ES | 1 |
| Chen, H; Cheng, L; Kang, Y; Li, L; Pan, C; Shu, X; Sun, M; Wei, Z | 1 |
| Du, Y; Liu, L; Ma, M; Shan, B; Sun, G; Yang, X; Zhang, C; Zhao, L | 1 |
| Fang, Y; Kopeček, J; Yang, J; Zhang, L | 1 |
| Keller, U; Licht, T; Menzel, H; Müller, A; Peschel, C; Von Schilling, C | 1 |
| Avilés, A; Díaz-Maqueo, JC; Fernández, R; García, EL; Gonzalez, JL; Neri, N | 1 |
| Baldini, L; Brugiatelli, M; Cavanna, L; Colombi, M; Federico, M; Gobbi, P; Goldaniga, M; Liberati, M; Lombardo, M; Luminari, S; Merli, F; Morabito, F; Sacchi, S; Silingardi, V; Stelitano, C | 1 |
| Avilés, A; Castañeda, C; Cleto, S; Huerta-Guzmán, J; Murillo, E; Nambo, MJ; Neri, N; Talavera, A | 1 |
| Bourgain, C; De Paepe, P; Serreyn, R; Van den Broecke, R; Van Renterghem, N | 1 |
| Broglia, C; Corazza, GR; Federico, M; Gobbi, PG; Lambelet, P; Lombardo, M; Luminari, S; Mammi, C; Merli, F; Polimeno, G; Riezzo, A; Rovati, A; Valentino, F | 1 |
| Aurran, T; Biron, P; Bouabdallah, R; Boulat, O; Chabannon, C; Chetaille, B; Coso, D; Esterni, B; Gastaut, JA; Ivanov, V; Maraninchi, D; Rey, J; Schiano de Collela, JM; Sebban, C; Stoppa, AM; Xerri, L | 1 |
| Beishuizen, A; de Man, R; Lam, KH; Pieters, R; van den Heuvel-Eibrink, MM; van Grotel, M | 1 |
| Leonard, JP; Siegel, AB | 1 |
| Baldini, L; Bertini, M; Botto, B; Cabras, G; Di Vito, F; Federico, M; Gallo, E; Liberati, AM; Luminari, S; Marcheselli, L; Merli, F; Mozzana, R; Naglieri, E; Orsucci, L; Pennese, E; Polimeno, G; Vitolo, U | 1 |
| Csomor, J; Egyed, M; Egyházi, Z; Fekete, S; Kaszás, I; Kollár, B; Pajor, L; Timár, B | 1 |
| Cerrina, J; Cosset, JM; Fernandez, H; Goldwasser, F; Hayat, M; Pico, JL; Pons, JC | 1 |
| Hayashi, T; Mori, S; Nomura, T; Nonaka, Y; Ogawa, M; Suzuki, T | 1 |
| Egami, K; Maeda, S; Matsuda, T; Okihama, Y; Onda, M; Wada, M; Yoshioka, M | 1 |
| Beyaert, R; Daniel, PT; Dörken, B; Essmann, F; Prokop, A; Schmelz, K; Schulze-Osthoff, K; Wieder, T | 1 |
| Angus, B; Carey, PJ; Conn, J; Culligan, D; Haynes, A; Iqbal, A; Jackson, GH; Lennard, AL; Leonard, RC; Lucraft, H; Proctor, SJ; Russel, N; Stark, A; Taylor, PR; Wood, K | 1 |
| Bollas, G; Dervenoulas, J; Economopoulos, T; Kalantzis, D; Koumarianou, A; Mantzios, G; Papageorgiou, E; Raptis, S; Rontogianni, D; Tsirigotis, P | 1 |
2 review(s) available for epirubicin and Lymphoma, B-Cell
| Article | Year |
|---|---|
Primary lymphoma of the cervix uteri: a diagnostic challenge. Report of two cases and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, B-Cell; Middle Aged; Neoplasm Staging; Prednisone; Uterine Cervical Neoplasms; Vincristine; Vindesine | 2005 |
[Diffuse B-cell lymphoma associated with hemophagocytic syndrome].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Prednisolone; Vincristine | 1998 |
8 trial(s) available for epirubicin and Lymphoma, B-Cell
| Article | Year |
|---|---|
Ifosfamide, epirubicin and etoposide rituximab in refractory or relapsed B-cell lymphoma: analysis of remission induction and stem cell mobilization.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Fever; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Middle Aged; Remission Induction; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome | 2008 |
Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Prednisone; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
Treatment of indolent B-Cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, B-Cell; Lymphoma, Follicular; Male; Middle Aged; Prednisone; Recombinant Proteins; Survival Analysis; Treatment Outcome | 2003 |
Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma: malignant lymphoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Male; Middle Aged; Prednisone; Prognosis; Risk Factors; Survival Analysis; Time Factors; Treatment Outcome; Vincristine | 2004 |
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 2006 |
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Prognosis; Rituximab; Survival Analysis; Transplantation, Autologous; Vincristine | 2006 |
Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Quality of Life; Survival Rate; Time Factors; Treatment Outcome; Vinblastine; Vincristine | 2007 |
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Recurrence; Salvage Therapy; Survival Rate; Treatment Outcome | 2001 |
12 other study(ies) available for epirubicin and Lymphoma, B-Cell
| Article | Year |
|---|---|
Subclinical Anthracycline-Induced Cardiotoxicity in the Long - Term Follow-Up of Lymphoma Survivors: A Multi-Layer Speckle Tracking Analysis.
Topics: Adult; Aged; Analysis of Variance; Anthracyclines; Antibiotics, Antineoplastic; Cardiotoxicity; Case-Control Studies; Cross-Sectional Studies; Echocardiography; Epirubicin; Female; Follow-Up Studies; Heart; Humans; Lymphoma, B-Cell; Male; Middle Aged; Myocardium; Observer Variation; Reference Values; Risk Factors; Statistics, Nonparametric; Stroke Volume; Ventricular Dysfunction, Left; Young Adult | 2018 |
Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Rituximab; Skin Neoplasms; Treatment Outcome; Vincristine | 2013 |
Early detection of anthracycline-induced cardiotoxicity using two-dimensional speckle tracking echocardiography.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Asymptomatic Diseases; Early Diagnosis; Epirubicin; Female; Heart Diseases; Humans; Lymphoma, B-Cell; Male; Middle Aged; Myocardial Contraction; Observer Variation; Predictive Value of Tests; Reproducibility of Results; Stroke Volume; Time Factors; Ultrasonography; Ventricular Function, Left | 2013 |
Mda-7/IL-24 enhances sensitivity of B cell lymphoma to chemotherapy drugs.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epirubicin; Gene Expression; Humans; Interleukins; Lymphoma, B-Cell; MAP Kinase Signaling System; Multidrug Resistance-Associated Proteins; Polycomb Repressive Complex 1; Vinblastine | 2016 |
A new construct of antibody-drug conjugates for treatment of B-cell non-Hodgkin's lymphomas.
Topics: Acrylamides; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Epirubicin; Fluorescent Dyes; Heterografts; Humans; Lymphoma, B-Cell; Male; Mice, SCID; Microscopy, Confocal; Neoplasm Transplantation; Rituximab; Tissue Distribution | 2017 |
High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, B-Cell; Male; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Vinblastine | 2006 |
Therapy for older patients with diffuse large cell lymphoma: targeting the treatment to the patient.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisone; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Prolonged survival using anti-CD20 combined chemotherapy in primary prostatic intravascular large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Prostatectomy; Prostatic Neoplasms; Rituximab; Survival | 2008 |
Successful chemotherapy including epirubicin in a pregnant non-Hodgkin's lymphoma patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Follow-Up Studies; Humans; Infant, Newborn; Lymphoma, B-Cell; Neoplasm Staging; Prednisolone; Pregnancy; Pregnancy Complications, Neoplastic; Time Factors; Vincristine | 1995 |
Complete cure of malignant lymphoma of the stomach with a huge adrenal lesion achieved by preoperative chemotherapy and surgery: report of a case.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Gastrectomy; Humans; Infusions, Intravenous; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoadjuvant Therapy; Prednisolone; Stomach Neoplasms; Treatment Outcome; Vincristine | 2001 |
Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.
Topics: Adaptor Proteins, Signal Transducing; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Bone Marrow; Carrier Proteins; Caspase 3; Caspase 8; Caspase 9; Caspases; Child; Epirubicin; Fas Ligand Protein; fas Receptor; Fas-Associated Death Domain Protein; Humans; Immunoblotting; Lymphoma, B-Cell; Membrane Glycoproteins; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transfection; Tumor Cells, Cultured | 2001 |
T-cell-rich B-cell lymphoma. Analysis of clinical features, response to treatment, survival and comparison with diffuse large B-cell lymphoma.
Topics: Aged; Antigens, CD; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; Humans; Immunohistochemistry; Liver; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisolone; Prednisone; Retrospective Studies; Spleen; Survival Rate; T-Lymphocytes; Time Factors; Vincristine | 2001 |